AHCLNSEANLON HEALTHCARE LIMITEDMediumNeutral
Announced Wed, 12 Aug · 14:51 IST

Anlon Q1 FY27 transcript: revenue up, margin dip, FY27 guide 380-400 cr

Mgmt Guided Margin ImprovementMgmt Guided Margin PressurePromoter Disclosed Acquisition PlansOrder Pipeline DisclosedAnalyst Day Multiyear TargetsInvestor Communications View source PDFExplain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹14.41
prior close
₹14.25
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0-0.1-0.2-0.8+0.8+0.5+1.0+0.0-0.2
Up moveDown movePending
AI summary

Q1 FY27 consolidated revenue rose to 87.62 cr from 33.31 cr YoY, helped by Remember India consolidation. EBITDA at 15.65 cr, PAT at 8.28 cr. EBITDA margin slipped to about 17% due to a sharp rise in solvent and raw material prices tied to the geopolitical situation and Remember India being in a turnaround phase. Management guides margin recovery to 25 to 30 percent by Q2 to Q3 FY27. FY27 revenue target held at 350 to 400 cr, FY28 target about 700 cr supported by 130 cr CAPEX adding 1200 MT capacity. PAT margin guided at 12 to 13 percent.

Likely market impact

Near-term margin pressure from raw material costs and acquisition integration, but revenue scaling and capacity expansion support medium-term growth.